Literature DB >> 12823498

Highly disabling cerebellar presentation in Huntington disease.

F Squitieri1, G Pustorino, M Cannella, A Toscano, V Maglione, L Morgante, G Tortorella.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12823498     DOI： 10.1046/j.1468-1331.2003.00601.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  7 in total

1.  Managing juvenile Huntington's disease.

Authors:  Oliver W J Quarrell; Martha A Nance; Peggy Nopoulos; Jane S Paulsen; Jonathan A Smith; Ferdinando Squitieri
Journal:  Neurodegener Dis Manag       Date:  2013-06-01

Review 2.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

3.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

4.  Current Pharmacological Management in Juvenile Huntington's Disease.

Authors:  Lisa Robertson; Helen Santini; Kirsty L O'Donovan; Ferdinando Squitieri; Roger A Barker; Maria Rakowicz; G Bernhard Landwehrmeyer; Oliver Quarrell
Journal:  PLoS Curr       Date:  2012-02-15

5.  A universal mechanism ties genotype to phenotype in trinucleotide diseases.

Authors:  Shai Kaplan; Shalev Itzkovitz; Ehud Shapiro
Journal:  PLoS Comput Biol       Date:  2007-10-16       Impact factor: 4.475

6.  Is Ataxia an Underestimated Symptom of Huntington's Disease?

Authors:  Gustavo L Franklin; Carlos Henrique F Camargo; Alex T Meira; Giovana M Pavanelli; Sibele S Milano; Francisco B Germiniani; Nayra S C Lima; Salmo Raskin; Orlando Graziani Povoas Barsottini; José Luiz Pedroso; Fernanda Aparecida Maggi; Vitor Tumas; Pedro Manzke de Carvalho; Ana Carolina de Oliveira; Bárbara Braga; Laura Cristina Souza; Rachel Paes Guimarães; Luiza Gonzaga Piovesana; Íscia Teresinha Lopes-Cendes; Paula Christina de Azevedo; Marcondes Cavalcante França; Alberto Rolim Muro Martinez; Hélio A G Teive
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

7.  Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease.

Authors:  Andras Salamon; Rita Maszlag-Török; Gábor Veres; Fanni Annamária Boros; Evelin Vágvölgyi-Sümegi; Anett Somogyi; László Vécsei; Péter Klivényi; Dénes Zádori
Journal:  Neurochem Res       Date:  2020-06-10       Impact factor: 4.414
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.